These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3221941)

  • 1. A comparison of three methods to assess metabolic control in diabetic patients on CAPD treatment.
    Bilo HJ; Struijk DG; Boeschoten EW; Oe PL; Donker AJ
    Neth J Med; 1988 Dec; 33(5-6):217-24. PubMed ID: 3221941
    [No Abstract]   [Full Text] [Related]  

  • 2. Fructosamine levels in CAPD: its value as glycemic index.
    Coronel F; Macia M; Cidoncha A; Sanchez A; Tornero F; Barrientos A; Valor R
    Adv Perit Dial; 1991; 7():253-6. PubMed ID: 1680438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of serum fructosamine in short term glycemic control.
    Prior TW; Chapman JF; Bankson DD
    Ann Clin Lab Sci; 1989; 19(2):107-13. PubMed ID: 2751240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycated haemoglobin and fructosamine in non-diabetic subjects with chronic renal failure.
    Morgan LJ; Marenah CB; Morgan AG; Burden RP; John WG
    Nephrol Dial Transplant; 1990; 5(10):868-73. PubMed ID: 2128382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of the metabolic condition in diabetics with renal insufficiency by means of the fructosamine test].
    Wagner R; Löwenstein I; Gieshoff B; Graben N; Olbricht T; Windeck R; Benker G; Reinwein D
    Dtsch Med Wochenschr; 1987 Jan; 112(5):175-7. PubMed ID: 3803236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Critical evaluation of fructosamine as a control parameter in the assessing diabetic metabolic control].
    Windeler J
    Klin Wochenschr; 1989 Oct; 67(20):1066-7. PubMed ID: 2586013
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of plasma fructosamine evaluated for monitoring diabetes.
    Lim YS; Staley MJ
    Clin Chem; 1985 May; 31(5):731-3. PubMed ID: 3921282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.
    Madden MA; Zimmerman SW; Simpson DP
    Am J Nephrol; 1982; 2(3):133-9. PubMed ID: 6758585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum fructosamine levels in diabetic glucose control].
    Koskinen P; Irjala K; Viikari J; Panula-Ontto R; Matikainen MT
    Duodecim; 1987; 103(2):80-6. PubMed ID: 3608867
    [No Abstract]   [Full Text] [Related]  

  • 13. [The value of fructosamine in the screening and evaluation of the metabolic control of the diabetic patient].
    Veillon H; Rieder A; Stara B; Darioli R
    Schweiz Rundsch Med Prax; 1988 May; 77(22):613-7. PubMed ID: 3387756
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assay for serum fructosamine in diabetes].
    Piaserico G; Piaserico P
    Quad Sclavo Diagn; 1986 Sep; 22(3):303-11. PubMed ID: 3615802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diabetic control by using hemoglobin A1 and fructosamine.
    Sridama V; Hansasuta P; Pasatrat S; Bunnag S
    J Med Assoc Thai; 1990 Mar; 73(3):130-5. PubMed ID: 2380644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum fructosamine: a parameter for monitoring metabolic control in diabetes.
    Gomo Z
    Cent Afr J Med; 1992 Sep; 38(9):358-62. PubMed ID: 1298563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose and cholesterol control improved by continuous ambulatory peritoneal dialysis in patients with end-stage renal disease and diabetes mellitus.
    Wikdahl AM; Granbom L; Sörensen JG; Stegmayr BG
    Perit Dial Int; 1993; 13 Suppl 2():S239-41. PubMed ID: 8399577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities.
    Guillausseau PJ; Charles MA; Paolaggi F; Timsit J; Chanson P; Peynet J; Godard V; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Care; 1990 Aug; 13(8):898-900. PubMed ID: 2209329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of fructosamine determination in diabetic patients and its relation to metabolic control.
    Daubresse JC; Laurent E; Ligny C; Bailly A; Lemy C; Duchateau A; Meunier JC
    Diabete Metab; 1987 Jun; 13(3):217-21. PubMed ID: 3609423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T; Tabata T; Nishizawa Y; Kikunami K; Matsushita Y; Inoue T; Kenmotsu M; Miki T; Morii H
    Nephron; 1989; 51(3):338-43. PubMed ID: 2918945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.